Collection and analysis of prostate cancer biospecimens
Biospecimen Core
['FUNDING_OTHER'] · DANA-FARBER CANCER INST · NIH-10916211
This study is looking for prostate cancer patients to share blood and tissue samples, which will help researchers better understand the disease and improve treatments, so your participation can make a real difference in patient care.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DANA-FARBER CANCER INST (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10916211 on ClinicalTrials.gov |
What this research studies
This research focuses on acquiring and characterizing biospecimens, such as blood and tissue samples, from prostate cancer patients to support translational research. By maintaining a biorepository linked with clinical data, the project aims to develop preclinical models that are relevant to patient care. The research involves collaboration with investigators to provide pathology services and advanced molecular assays, enhancing the understanding of prostate cancer and its treatment. Patients who consent to participate will contribute to a database that aids in the evaluation of treatment responses and disease progression.
Who could benefit from this research
Good fit: Ideal candidates for participation are prostate cancer patients who are willing to provide blood and tissue samples for research purposes.
Not a fit: Patients who do not have prostate cancer or are not willing to participate in biospecimen collection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for prostate cancer patients.
How similar studies have performed: Previous research has shown success in utilizing biospecimen banks to advance cancer treatment and understanding, indicating that this approach is both established and effective.
Where this research is happening
BOSTON, UNITED STATES
- DANA-FARBER CANCER INST — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: POMERANTZ, MARK M. — DANA-FARBER CANCER INST
- Study coordinator: POMERANTZ, MARK M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.